First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety.

ABSTRACT:

Background

Preeclampsia affects between 2% and 5% of pregnant people in North America. First-trimester preeclampsia screening based on the Fetal Medicine Foundation risk calculation algorithm combined with treatment of high-risk patients with aspirin effectively reduces the incidence of preterm preeclampsia more than the currently used risk factor-based screening. However, the impact of such screening on patient satisfaction and maternal anxiety is unknown.

Objective

This study aimed to assess the impact of first-trimester prediction and prevention of preterm preeclampsia on patient satisfaction and anxiety.

Study design

Consenting pregnant patients participating in a local first-trimester (11-13+6 weeks) preterm preeclampsia screening and prevention implementation st

SUBMITTER: Silang K 

PROVIDER: S-EPMC10165256 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature